SEC Comment Letter 0000000000-23-005902 to APPLIED DNA SCIENCES INC (APDN) (CIK 0000744452) (BNBX)
APPLIED DNA SCIENCES INC (APDN) (CIK 0000744452)
Date: June 2, 2023 · CIK: 0000744452 · Accession: 0000000000-23-005902
AI Filing Summary & Sentiment
File numbers found in text: 333-272267
Letter
United States securities and exchange commission logo June 2, 2023 Beth Jantzen Chief Financial Officer Applied DNA Sciences, Inc. 50 Health Sciences Drive Stony Brook, New York 11790 Re:Applied DNA Sciences, Inc. Registration Statement on Form S-3 Filed May 30, 2023 File No. 333-272267 Dear Beth Jantzen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jennie Beysolow at 202-551-8108 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Merrill M. Kraines, Esq.
Show Raw Text
United States securities and exchange commission logo
June 2, 2023
Beth Jantzen
Chief Financial Officer
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, New York 11790
Re:Applied DNA Sciences, Inc.
Registration Statement on Form S-3
Filed May 30, 2023
File No. 333-272267
Dear Beth Jantzen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jennie Beysolow at 202-551-8108 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc: Merrill M. Kraines, Esq.